Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Diabetes-Related Lower Extremity Amputations

Diabetes Care; ePub 2018 Nov 8; Geiss, et al

Following a 2-decade decline in diabetes-related lower extremity amputations, the US may now be experiencing a reversal in the progress, particularly in young and middle-aged. This according to a recent study that sought to determine whether declining trends in diabetes-related lower extremity amputations have continued into the current decade. Researchers calculated hospitalization rates for nontraumatic lower extremity amputation (NLEA) for the years 2000-2015 using nationally representative, serial cross-sectional data from the Nationwide Inpatient Sample on NLEA procedures and from the National Health Interview Survey for estimates of the populations with and without diabetes. They found:

  • Age-adjusted NLEA rates per 1,000 adults with diabetes decreased 43% between 2000 and 2009 but then rebounded by 50% between 2009 and 2015.
  • Conversely, age-adjusted NLEA rates per 1,000 adults without diabetes decreased from 0.23 per 1,000 in 2000 to 0.18 per 1,000 in 2015.
  • The increased in diabetes-related NLEA rates between 2009 and 2015 was driven by a 62% increase in the rate of minor amputations and a smaller but statistically significant 29% increase in major NLEAs.
  • These increases were most pronounced in young (aged 18-44 years) and middle-aged (aged 45-64 years) adults and more marked in men vs women.

Citation:

Geiss LS, Li Y, Hora I, Albright A, Rolka D, Gregg EW. Resurgence of diabetes-related nontraumatic lower extremity amputation in the young and middle-aged adult U.S. population. [Published online ahead of print November 8, 2018]. Diabetes Care. doi:10.2337/dc18-1380.

This Week's Must Reads

Androgen Deprivation Therapy & Risk of Depression, Cancer; ePub 2019 Feb 12; Deka, Rose, et al

QOL in Patients with Low-Risk PC Treated with HRT, JAMA Oncol; ePub 2019 Feb 14; Bruner, et al

Hospital Competition & Prostate Cancer Outcomes, Cancer; ePub 2019 Feb 1; Aggarwal, et al

Insurance Status & Stage of Prostate Ca Diagnosis, Cancer Epidemiol; 2019 Apr; Ramirez, Morano, et al

Agent Orange Exposure & Prostate Ca Outcomes, J Urol; ePub 2019 Jan 8; Etheridge, et al

Must Reads in Diabetes

Insulin Management in Patients with T2D, Lancet; ePub 2019 Feb 22; Bergenstal, et al

Hospitalization Rates in Young-Onset Diabetes, Ann Intern Med; ePub 2019 Jan 15; Ke, Lau, et al

Long-Term Absolute Risk for CVD by FG Level, Diabetes Care; ePub 2019 Jan 7; Bancks, et al

Prediabetes Status & Lifestyle Modification , J Am Board Fam Med; 2019 Jan 4; Owei, et al

Second-Line ADMs & CV Events in T2D, JAMA Netw Open; ePub 2018 Dec 21; O’Brien, et al